Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal.

R C Reiter, Paul Wagner, P L Wagner, J C Gambone, Joseph C. Gambone
Obstetrics and gynecology · 1992 · vol. 79(4) , pp. 481–4 · PMID:1553162 · W164013843
article OA: closed CC0 ⤵ 13 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study found no increase in adverse outcomes or blood loss for hysterectomies performed on uteri larger than 12 weeks' size, suggesting routine prophylactic hysterectomy for large asymptomatic fibroids is unnecessary.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

As part of an ongoing quality improvement process, the records of 104 consecutive patients undergoing hysterectomy for uterine leiomyomata were reviewed. The diagnosis was confirmed histologically in 93 cases (89%) and in eight of the remaining 11, other disease such as adenomyosis or an ovarian neoplasm was discovered. The 93 consecutive patients with a confirmed diagnosis of uterine leiomyomata were then stratified according to preoperative estimate of uterine size and actual uterine weight. The physician's clinical estimate of uterine size correlated well with specimen weight (r = 0.65, P less than .001). Intraoperative estimated blood loss correlated less well with actual change in hematocrit (r = 0.31, P = .03). Women with a uterine size estimate larger than 12 weeks' gestation were no more likely to suffer perioperative complications than were those with smaller uteri. Furthermore, there was no significant increase in mean estimated blood loss or blood transfusion in women with larger uteri compared with those with smaller uteri. We conclude that there is no increase in adverse short-term outcomes associated with hysterectomy for leiomyomata in women with uteri greater than 12 weeks' size. Therefore, hysterectomy need not be routinely recommended to asymptomatic women with larger uteri as prophylaxis against increased operative morbidity associated with future growth.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Hysterectomy Leiomyoma Uterine Neoplasms Uterus Adult Blood Loss, Surgical Female Humans Hysterectomy Intraoperative Complications Intraoperative Complications Leiomyoma Leiomyoma Leiomyoma Organ Size Postoperative Complications Postoperative Complications Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (13)

Source provenance

europepmc
last seen: 2026-06-21T06:12:49.409960+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:49.821429+00:00
License: CC0 · commercial use OK